1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Deferiprone Consumption Value by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Tablet
  • 1.3.3 Oral Solution
  • 1.3.4 Capsule
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Deferiprone Consumption Value by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Transfusional Iron Overload
  • 1.4.3 NTDT Caused Iron Overload
• 1.5 Global Deferiprone Market Size & Forecast
  • 1.5.1 Global Deferiprone Consumption Value (2020 & 2024 & 2031)
  • 1.5.2 Global Deferiprone Sales Quantity (2020-2031)
  • 1.5.3 Global Deferiprone Average Price (2020-2031)

2 Manufacturers Profiles

• 2.1 Apotex
  • 2.1.1 Apotex Details
  • 2.1.2 Apotex Major Business
  • 2.1.3 Apotex Deferiprone Product and Services
  • 2.1.4 Apotex Deferiprone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Apotex Recent Developments/Updates
• 2.2 Cipla
  • 2.2.1 Cipla Details
  • 2.2.2 Cipla Major Business
  • 2.2.3 Cipla Deferiprone Product and Services
  • 2.2.4 Cipla Deferiprone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Cipla Recent Developments/Updates

3 Competitive Environment: Deferiprone by Manufacturer

• 3.1 Global Deferiprone Sales Quantity by Manufacturer (2020-2025)
• 3.2 Global Deferiprone Revenue by Manufacturer (2020-2025)
• 3.3 Global Deferiprone Average Price by Manufacturer (2020-2025)
• 3.4 Market Share Analysis (2024)
  • 3.4.1 Producer Shipments of Deferiprone by Manufacturer Revenue ($MM) and Market Share (%): 2024
  • 3.4.2 Top 3 Deferiprone Manufacturer Market Share in 2024
  • 3.4.3 Top 6 Deferiprone Manufacturer Market Share in 2024
• 3.5 Deferiprone Market: Overall Company Footprint Analysis
  • 3.5.1 Deferiprone Market: Region Footprint
  • 3.5.2 Deferiprone Market: Company Product Type Footprint
  • 3.5.3 Deferiprone Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Deferiprone Market Size by Region
  • 4.1.1 Global Deferiprone Sales Quantity by Region (2020-2031)
  • 4.1.2 Global Deferiprone Consumption Value by Region (2020-2031)
  • 4.1.3 Global Deferiprone Average Price by Region (2020-2031)
• 4.2 North America Deferiprone Consumption Value (2020-2031)
• 4.3 Europe Deferiprone Consumption Value (2020-2031)
• 4.4 Asia-Pacific Deferiprone Consumption Value (2020-2031)
• 4.5 South America Deferiprone Consumption Value (2020-2031)
• 4.6 Middle East & Africa Deferiprone Consumption Value (2020-2031)

5 Market Segment by Type

• 5.1 Global Deferiprone Sales Quantity by Type (2020-2031)
• 5.2 Global Deferiprone Consumption Value by Type (2020-2031)
• 5.3 Global Deferiprone Average Price by Type (2020-2031)

6 Market Segment by Application

• 6.1 Global Deferiprone Sales Quantity by Application (2020-2031)
• 6.2 Global Deferiprone Consumption Value by Application (2020-2031)
• 6.3 Global Deferiprone Average Price by Application (2020-2031)

7 North America

• 7.1 North America Deferiprone Sales Quantity by Type (2020-2031)
• 7.2 North America Deferiprone Sales Quantity by Application (2020-2031)
• 7.3 North America Deferiprone Market Size by Country
  • 7.3.1 North America Deferiprone Sales Quantity by Country (2020-2031)
  • 7.3.2 North America Deferiprone Consumption Value by Country (2020-2031)
  • 7.3.3 United States Market Size and Forecast (2020-2031)
  • 7.3.4 Canada Market Size and Forecast (2020-2031)
  • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

• 8.1 Europe Deferiprone Sales Quantity by Type (2020-2031)
• 8.2 Europe Deferiprone Sales Quantity by Application (2020-2031)
• 8.3 Europe Deferiprone Market Size by Country
  • 8.3.1 Europe Deferiprone Sales Quantity by Country (2020-2031)
  • 8.3.2 Europe Deferiprone Consumption Value by Country (2020-2031)
  • 8.3.3 Germany Market Size and Forecast (2020-2031)
  • 8.3.4 France Market Size and Forecast (2020-2031)
  • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
  • 8.3.6 Russia Market Size and Forecast (2020-2031)
  • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

• 9.1 Asia-Pacific Deferiprone Sales Quantity by Type (2020-2031)
• 9.2 Asia-Pacific Deferiprone Sales Quantity by Application (2020-2031)
• 9.3 Asia-Pacific Deferiprone Market Size by Region
  • 9.3.1 Asia-Pacific Deferiprone Sales Quantity by Region (2020-2031)
  • 9.3.2 Asia-Pacific Deferiprone Consumption Value by Region (2020-2031)
  • 9.3.3 China Market Size and Forecast (2020-2031)
  • 9.3.4 Japan Market Size and Forecast (2020-2031)
  • 9.3.5 South Korea Market Size and Forecast (2020-2031)
  • 9.3.6 India Market Size and Forecast (2020-2031)
  • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
  • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

• 10.1 South America Deferiprone Sales Quantity by Type (2020-2031)
• 10.2 South America Deferiprone Sales Quantity by Application (2020-2031)
• 10.3 South America Deferiprone Market Size by Country
  • 10.3.1 South America Deferiprone Sales Quantity by Country (2020-2031)
  • 10.3.2 South America Deferiprone Consumption Value by Country (2020-2031)
  • 10.3.3 Brazil Market Size and Forecast (2020-2031)
  • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

• 11.1 Middle East & Africa Deferiprone Sales Quantity by Type (2020-2031)
• 11.2 Middle East & Africa Deferiprone Sales Quantity by Application (2020-2031)
• 11.3 Middle East & Africa Deferiprone Market Size by Country
  • 11.3.1 Middle East & Africa Deferiprone Sales Quantity by Country (2020-2031)
  • 11.3.2 Middle East & Africa Deferiprone Consumption Value by Country (2020-2031)
  • 11.3.3 Turkey Market Size and Forecast (2020-2031)
  • 11.3.4 Egypt Market Size and Forecast (2020-2031)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
  • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

• 12.1 Deferiprone Market Drivers
• 12.2 Deferiprone Market Restraints
• 12.3 Deferiprone Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Deferiprone and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Deferiprone
• 13.3 Deferiprone Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Deferiprone Typical Distributors
• 14.3 Deferiprone Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Deferiprone market size was valued at US$ 39.6 million in 2024 and is forecast to a readjusted size of USD 49.3 million by 2031 with a CAGR of 3.2% during review period.
Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.
Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Those two totally got about 96% market shares.
North America is the largest consumption region of Deferiprone, with a consumption value market share nearly 28%. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24%.
This report is a detailed and comprehensive analysis for global Deferiprone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Deferiprone market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Deferiprone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Deferiprone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Deferiprone market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Deferiprone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Deferiprone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Apotex, Cipla, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Deferiprone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablet
Oral Solution
Capsule
Market segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload
Major players covered
Apotex
Cipla
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Deferiprone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Deferiprone, with price, sales quantity, revenue, and global market share of Deferiprone from 2020 to 2025.
Chapter 3, the Deferiprone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Deferiprone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Deferiprone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Deferiprone.
Chapter 14 and 15, to describe Deferiprone sales channel, distributors, customers, research findings and conclusion.